News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

The Texas Hepatocellular Carcinoma Consortium (THCCC); Risk Stratification For and Early Detection of Liver Cancer (U01)

Study Status:

Not Yet Recruiting

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The purpose of this study is the identification of risk factors and early detection of HCC with emphasis on the high-risk Cirrhotic patient population.

Information: 

Principal Investigator
Rashmee Patil, MD
Sponsor
Baylor College of Medicine
Type of Trial
Observational
DHRHealth Institute for Research and Development
5323 S. McColl Rd., Edinburg, TX 78539
(956) 362-2390
© 2022 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank